Paternal Lymphocyte Immunisation (LIT/PLI)

What is Paternal Lymphocyte Immunisation?

Lymphocyte immunotherapy (LIT), often called paternal lymphocyte immunisation (PLI), is an experimental treatment that has been offered to women with recurrent pregnancy loss. Lymphocytes are a type of white blood cell. In this approach, a sample of the father's blood is collected, the white blood cells are separated in a laboratory, and they are then injected into the mother, usually before a new pregnancy. PLI was developed with the aim of helping the mother’s immune system build tolerance to foreign tissues. LIT or PLI has also been explored in IVF after several unsuccessful treatment cycles, but its effectiveness remains unproven.

How Is the Procedure Done?

If your clinic offers paternal lymphocyte immunisation, the procedure may look like:

1. Blood Sample: A blood sample is retrieved from the father
2. Lab Preparation: The lab separates white blood cells from the sample and prepares them for injection.
3. Injection: The WBCs are then injected into the mother’s forearm (shallow intradermal or subcutaneous injections).
4. Repeat Sessions: You may need to have two to three sessions spaced a few weeks apart.
5. Follow-up: Blood tests might be done afterwards to determine if the mother’s body has responded to the cells.

Couples are usually advised to wait about four weeks after the completion of treatment before trying for a baby.

What Does the Research Say?

The best way to judge a treatment is to look at many well-run trials together.

In 2025, a study was published explaining the case of a 28-year-old woman who suffered repeated miscarriages during the first trimester and unsuccessful ICSI attempts before she conceived and gave birth to a healthy baby through lymphocyte immunotherapy. LIT was performed 6 weeks before a new ICSI cycle. The results showed positive findings on the following ultrasounds and hormone levels at week 6, week 8, and week 12. Eventually, she gave birth to a healthy baby. However, other studies have not been as promising.

Cochrane Collaboration and ESHRE showed:

Possible Risks Associated with LIT/PLI

LIT is generally considered a low-risk procedure, and its side effects are similar to those of standard intradermal vaccines. You may notice:

• Mild to moderate redness, swelling, or itching at the injection site. It should resolve by itself in a couple of weeks.
• Though rare, some patients may experience blistering.
• Temporary bluish-reddish spots or discolourations.
• Flu symptoms such as mild fever, fatigue or a general feeling of illness. Also uncommon.
• Risk of blood-borne infection transmission if healthcare providers do not follow screening protocols properly.
• Emotional strain. Going through weeks of treatment, then facing another loss, can feel emotionally crushing.
• Lost time in couples where age is a factor. Spending months on a treatment that may or may not work can delay getting actual care that can help.

What Actually Helps After Repeated Pregnancy Loss

The good news is that recurrent loss is a medical problem, and proper investigation can resolve it.

• Genetic checks: Chromosome problems in the embryo are the most common reason for early miscarriage. Sometimes, testing the couple's chromosomes is advised.
• Womb assessment: A scan can show whether the shape of the uterus plays a role in repeated pregnancy loss.
• Blood tests for clotting and hormone conditions: Conditions like antiphospholipid syndrome or thyroid disease can affect pregnancy outcomes. These may be manageable once discussed by a specialist.
• Lifestyle review: Smoking, heavy alcohol use, and very high or low body weight are linked with a higher risk of miscarriages.
• Supportive care: Early monitoring and emotional support in the next pregnancy make a real difference. Studies of dedicated early pregnancy care have shown reassuring outcomes for many couples.

Not every couple will need every test. The aim is to find a cause when one exists and to avoid unproven steps when it doesn't.

When to Speak to a Specialist

Many guidelines suggest seeking assessment after two or more pregnancy losses. Do not wait until you have been through repeated heartbreak. Look for a fertility or recurrent pregnancy loss specialist who explains the evidence openly, including what is not known. If a clinic promises that a treatment will "fix" your immune system, ask for the published research behind it. A good doctor will welcome the question.

Conclusion

Lymphocyte immunotherapy, or paternal lymphocyte immunisation, involves injecting the father’s white blood cells into the mother with the aim of building immune tolerance towards the embryo. LIT/PLI began as an appealing idea that offered hope to many couples. However, research has not consistently shown that it improves live birth rates. Many major international guidelines do not recommend it for treating recurrent pregnancy loss.

For couples facing recurrent pregnancy loss, a more evidence-based approach involves a thorough, step-by-step medical evaluation, emotional support, and close monitoring during the next pregnancy. The chances of having a healthy baby after pregnancy loss are often better than many people fear. Accurate information is the first step towards making calm, confident decisions.